Literature DB >> 28534186

Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder.

Andrea Murru1, Isabella Pacchiarotti1, Norma Verdolini1,2, Maria Reinares1, Carla Torrent1, Pierre-Alexis Geoffroy3,4,5,6, Frank Bellivier3,4,5,6, Pierre-Michel Llorca6,7, Eduard Vieta1, Ludovic Samalin8,9.   

Abstract

The chronic, long-term evolution of bipolar disorder (BD) requires a careful clinical characterization with prognostic implications in terms of symptom and functional control. The OPTHYMUM multicenter study was conducted in France with the objective of evaluating residual symptoms on overall functioning of BD patients during inter-episodic period. The aims of the present study were to identify the potentially modifiable (e.g., treatable) and non-modifiable variables associated with functional impairment during the inter-episodic periods of BD. Sample was divided into two groups according to level of functioning (adequate vs. impaired), based on the FAST scale total score. FAST cut-off for functional impairment is a score >11. The two subgroups were compared as per sociodemographic and clinical variables with standard univariate analyses, and a logistic regression model was created. The model as a whole contained independent non-modifiable factors (age, gender, BD type, illness duration) and modifiable factors (illness severity, predominant polarity, depressive and manic residual symptoms, comorbidities). The final model was statistically significant (χ 2 = 53.89, df = 5, p < 0.001). Modifiable factors most strongly associated with functional impairment were manic predominant polarity (OR = 1.79, CI 95% 1.09-2.96, p = 0.022), residual depressive symptoms (OR = 1.30, CI 95% 1.18-1.43, p < 0.001) and illness severity (OR = 1.24, CI 95% 1.01-1.52, p = 0.037), whilst non-modifiable factor was illness duration (OR = 1.03, CI 95% 1.01-1.05, p = 0.017). Despite intrinsic and non-modifiable illness characteristics, a clinical-wise choice of treatment may help to improve control of manic relapses. Potential improvement of residual depressive symptoms may alleviate the functional burden associated with bipolar disorder.

Entities:  

Keywords:  Bipolar disorder; Functioning; Inter-episodic periods; Predominant polarity; Residual symptoms

Mesh:

Year:  2017        PMID: 28534186     DOI: 10.1007/s00406-017-0811-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  41 in total

1.  Predominant polarity in bipolar disorders: refining or redefining diagnosis?

Authors:  F Colom; E Vieta; T Suppes
Journal:  Acta Psychiatr Scand       Date:  2015-09-14       Impact factor: 6.392

2.  The association between insomnia-related sleep disruptions and cognitive dysfunction during the inter-episode phase of bipolar disorder.

Authors:  Jennifer C Kanady; Adriane M Soehner; Alexandra B Klein; Allison G Harvey
Journal:  J Psychiatr Res       Date:  2017-01-05       Impact factor: 4.791

3.  Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study.

Authors:  Sanna Pallaskorpi; Kirsi Suominen; Mikko Ketokivi; Outi Mantere; Petri Arvilommi; Hanna Valtonen; Sami Leppämäki; Erkki Isometsä
Journal:  Bipolar Disord       Date:  2015-03-02       Impact factor: 6.744

4.  Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

Authors:  M K Spearing; R M Post; G S Leverich; D Brandt; W Nolen
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

5.  Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options.

Authors:  Alessandra M A Nivoli; Francesc Colom; Isabella Pacchiarotti; Andrea Murru; Jan Scott; Marc Valentí; Lorenzo Mazzarini; Caterina Del Mar Bonnin; José Sánchez-Moreno; Alessandro Serretti; Eduard Vieta
Journal:  Eur Neuropsychopharmacol       Date:  2012-08-28       Impact factor: 4.600

6.  Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence.

Authors:  Carlos López-Jaramillo; Juan Lopera-Vásquez; Aurora Gallo; Jorge Ospina-Duque; Vaughan Bell; Carla Torrent; Anabel Martínez-Arán; Eduard Vieta
Journal:  Bipolar Disord       Date:  2010-08       Impact factor: 6.744

7.  Treatment adherence in bipolar I and schizoaffective disorder, bipolar type.

Authors:  A Murru; I Pacchiarotti; B L Amann; A M A Nivoli; E Vieta; F Colom
Journal:  J Affect Disord       Date:  2013-09-03       Impact factor: 4.839

8.  Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder.

Authors:  Ludovic Samalin; Ingrid de Chazeron; Eduard Vieta; Frank Bellivier; Pierre-Michel Llorca
Journal:  Bipolar Disord       Date:  2016-03-06       Impact factor: 6.744

9.  Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial.

Authors:  F Colom; E Vieta; J Sánchez-Moreno; R Palomino-Otiniano; M Reinares; J M Goikolea; A Benabarre; A Martínez-Arán
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

Review 10.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta; Allan Young; Lakshmi Yatham; Heinz Grunze; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

View more
  8 in total

1.  Impaired recovery in affective disorders and schizophrenia: sharing a common pathophysiology?

Authors:  Peter Falkai; Andrea Schmitt; Nikolaos Koutsouleris
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-12       Impact factor: 5.270

2.  Prevalence and clinical correlates of residual symptoms in remitted patients with bipolar disorder: An exploratory study.

Authors:  Sandeep Grover; Subho Chakrabarti; Swapnajeet Sahoo
Journal:  Indian J Psychiatry       Date:  2020-05-15       Impact factor: 1.759

Review 3.  Patients' adherence to smartphone apps in the management of bipolar disorder: a systematic review.

Authors:  Marie-Camille Patoz; Diego Hidalgo-Mazzei; Bruno Pereira; Olivier Blanc; Ingrid de Chazeron; Andrea Murru; Norma Verdolini; Isabella Pacchiarotti; Eduard Vieta; Pierre-Michel Llorca; Ludovic Samalin
Journal:  Int J Bipolar Disord       Date:  2021-06-03

Review 4.  The Impact of Subsyndromal Bipolar Symptoms on Patient's Functionality and Quality of Life.

Authors:  Heinz Grunze; Christoph Born
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

5.  Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder.

Authors:  Caterina Del Mar Bonnín; María Reinares; Anabel Martínez-Arán; Esther Jiménez; Jose Sánchez-Moreno; Brisa Solé; Laura Montejo; Eduard Vieta
Journal:  Int J Neuropsychopharmacol       Date:  2019-08-01       Impact factor: 5.176

Review 6.  Lithium's antiviral effects: a potential drug for CoViD-19 disease?

Authors:  Andrea Murru; Mirko Manchia; Tomas Hajek; René E Nielsen; Janusz K Rybakowski; Gabriele Sani; Thomas G Schulze; Leonardo Tondo; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2020-05-20

7.  Psychoeducation in bipolar disorder: A systematic review.

Authors:  Juliana Lemos Rabelo; Breno Fiuza Cruz; Jéssica Diniz Rodrigues Ferreira; Bernardo de Mattos Viana; Izabela Guimarães Barbosa
Journal:  World J Psychiatry       Date:  2021-12-19

8.  Real-World Functioning in Psychiatric Outpatients: Predictive Factors.

Authors:  Paola Bozzatello; Benedetta Giordano; Cristiana Montemagni; Paola Rocca; Silvio Bellino
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.